Aug 4, 2026 07:24AM
Aug 4, 2026 07:00AM
May 14, 2026 07:34AM
May 14, 2026 07:00AM
Mar 19, 2026 07:57AM
Mar 19, 2026 07:00AM
Nov 5, 2025 04:14PM Larimar Therapeutics, Inc. (LRMR) Misses Q3 EPS by 20c
Nov 5, 2025 07:00AM
Aug 14, 2025 07:24AM
Aug 14, 2025 07:00AM
Apr 30, 2025 07:00AM
Mar 25, 2025 12:52PM
Mar 24, 2025 07:03AM
Mar 24, 2025 07:01AM Larimar Therapeutics (LRMR) Provides Nomlabofusp Development Update
Mar 24, 2025 07:00AM
Dec 16, 2024 02:38PM
Oct 30, 2024 04:23PM
Oct 30, 2024 07:00AM
Aug 7, 2024 07:00AM
May 9, 2024 05:03PM
May 9, 2024 07:00AM Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
Mar 14, 2024 04:05PM
Nov 14, 2023 07:30AM
Nov 14, 2023 07:00AM
Aug 10, 2023 07:04AM
Aug 10, 2023 07:00AM
May 15, 2023 07:02AM
May 15, 2023 07:00AM Larimar Therapeutics Reports Preliminary Top-line Data from Phase 2 Trial’s 25 mg Cohort Showing Increases in Frataxin Levels in Patients with Friedreich’s Ataxia and First Quarter 2023 Financial
Mar 14, 2023 07:00AM
Nov 10, 2022 07:00AM
Aug 11, 2022 04:09PM
Aug 11, 2022 04:05PM
May 12, 2022 07:00AM
Mar 25, 2022 07:00AM
Nov 12, 2021 07:00AM Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
Aug 12, 2021 07:00AM
May 10, 2021 04:05PM
Mar 4, 2021 07:00AM
Nov 10, 2020 08:00AM
Nov 10, 2020 08:00AM
Aug 11, 2020 07:00AM
Aug 11, 2020 07:00AM Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results

1,219,016 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All